XML 31 R25.htm IDEA: XBRL DOCUMENT v2.4.0.8
Note 5 - Stockholders' Equity (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2013
Dec. 31, 2012
Stockholders' Equity Note [Abstract]    
Common Stock Reserved For Future Issuance [Table Text Block]

Common Stock Purchase Warrants

    8,292,226  

Equity Incentive Plans

    1,197,529  

Series A Convertible Preferred Stock

    1,050,667  

Total

    10,540,422  
 
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]
   

Number of Shares

   

Weighted Average

Exercise Price

 

Outstanding at December 31, 2012

    1,069,141     $ 4.50  

Granted

    --       --  

Exercised

    --       --  

Forfeited or expired

    (78,429 )     4.86  

Outstanding at September 30, 2013

    990,712     $ 4.47  

Exercisable at September 30, 2013

    679,036     $ 6.14  
   
Number
of Shares
   
Weighted-
Average
Exercise
Price
   
Weighted-
Average
Remaining
Contractual
Term (yrs)
   
Aggregate
Intrinsic
Value
 
Outstanding at December 31, 2011
    928,242     $ 5.43              
Granted
    238,500       0.70              
Exercised
    -       -              
Forfeited or expired
    (97,601 )     4.02              
Outstanding at December 31, 2012
    1,069,141     $ 4.50       6.2     $ -0-  
Exercisable at December 31, 2012
    698,995     $ 6.38       4.6     $ -0-  
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]
   

Number of Shares

   

Weighted Average

Exercise Price

 

Outstanding at December 31, 2012

    11,225,559     $ 2.06  

Issued

    --       --  

Exercised

    (2,933,333 )     0.56  

Forfeited or expired

    --       --  

Outstanding at September 30, 2013

    8,292,226     $ 2.53  

Exercisable at September 30, 2013

    8,292,226     $ 2.53  
   
Number of Shares
   
Weighted Average
Exercise Price
 
Outstanding at December 31, 2011
    1,870,559     $ 7.96  
Issued – Series A Warrants (1)
    2,933,333       1.00  
Issued – Series B Warrants (1)
    2,933,333       0.75  
Issued – Series C Warrants (1)
    2,933,333       1.00  
Issued – Other Warrants (2)
    612,001       1.00  
Exercised
    --       --  
Forfeited or expired
    (57,000 )     7.00  
Outstanding at December 31, 2012
    11,225,559     $ 2.06  
Exercisable at December 31, 2012
    8,290,376     $ 2.44  
Allocation of Net Proceeds from Preferred Stock Financing [Table Text Block]  
Net proceeds after transaction costs
  $ 1,999,032  
Less:       Fair value of warrants (recorded to Additional Paid-in Capital)
    (1,127,418 )
Beneficial conversion feature (recorded to Additional Paid-in Capital)
    (762,667 )
Net proceeds allocated to preferred stock
    108,947  
Accretion of beneficial conversion feature (deemed dividend)
    762,667  
Initial carrying value of preferred stock
    871,614  
Conversions to common stock
    (559,418 )
Carrying value of preferred stock at December 31, 2012
  $ 312,196  
Additional Information Concerning Stock Options [Table Text Block]  
   
2012
   
2011
   
2010
 
Weighted average fair value of options granted during the period
  $ 0.59     $ 0.79     $ 2.95  
Intrinsic value of options exercised during the period
    -       -       -  
Total fair value of options vested during the period
    319,920       540,339       499,557  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]  
   
2012
   
2011
   
2010
 
Weighted average risk-free interest rates
    1.1 %     1.4 %     2.6 %
Expected dividend yield
    0.0 %     0.0 %     0.0 %
Expected life of option (yrs)
 
6.7
   
7
   
6.7
 
Expected volatility
    105.2 %     111.2 %     112.9 %
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]  
   
2012
   
2011
   
2010
 
General and administrative expense
  $ 231,936     $ 284,352     $ 369,161  
Research and development expense
    78,140       179,400       206,501  
Total stock option expense
  $ 310,076     $ 463,752     $ 575,662